Table 2.
Reported proportion of IMM compliance (%) and observed proportion of IMM target achievement (%) in responders and non-responders.
| Response | Baseline | 1 month | 6 months | |||
|---|---|---|---|---|---|---|
| Yes | No | Yes | No | Yes | No | |
| IMM compliance | ||||||
| antiplatelets | 100.0 | 100.0 | 90.9 | 90.0 | 100.0 | 100.0 |
| statins | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| BP medications | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| DM treatment | 100.0 | 100.0 | 100.0 | 100.0 | 81.8 | 80.0 |
| IMM target achievementa | ||||||
| LDL ≤ 70 mg/dL | 54.5 | 50.0 | 72.7 | 60.0 | 54.5 | |
| SBP ≤ 150 mmHg | 63.6 | 70.0 | 54.5 | 60.0 | 63.6 | |
| HbA1c ≤ 7% | 63.6 | 70.0 | 72.7 | 80.0 | 72.7 | |
| vigorous physical activity | 27.3 | 20.0 | 36.3 | 40.0 | 54.5 | |
| smoking cessation | 72.7 | 80.0 | 81.8 | 100.0 | 100.0 | |
aThe target achievement was evaluated until any recurrence of ischemic event.
IMM, intensive medical management; BP, blood pressure; DM, diabetes mellitus; LDL, low-density lipoprotein; SBP, systolic blood pressure; HbA1c, glycated hemoglobin A1c.